Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.First subject dosed in phase 1 trial of BMS-986179 with Enhanze technology
Image: Halozyme has announced first clinical dosing in phase 1 trial of BMS-986179 with Enhanze technology. Photo: courtesy of suphakit73 / FreeDigitalPhotos.net.
Image: Halozyme has announced first clinical dosing in phase 1 trial of BMS-986179 with Enhanze technology. Photo: courtesy of suphakit73 / FreeDigitalPhotos.net.